PROX1 and leukemia: Consistently, expression of LN892 and SENCR in GEPIA as well as PROX1-AS1 and KIF25-AS1 in Bloodspot (Leukemia MILE Study) is much higher in leukemia patients than those in normal donors (Figure S5a, S5b) with barely or undetectable expression of LN892 in both datasets.